O

Orakl Oncology

AI-driven tumor modeling for personalized oncology

Alliance & Delivery Manager - Pharma Partnerships

Program ManagementConfirmed live in the last 24 hours
Full-timeNo salary listedHybrid

About the Job

Requirements

  • At least 4 years of project management, alliance management, account management, or partner delivery experience in biotech, pharma, a contract research organization, or techbio.
  • A master's degree in a scientific or engineering field.
  • Demonstrated experience leading multidisciplinary scientific projects from planning through final deliverables, including adapting when results reshape the plan.
  • Experience managing pharma stakeholders through steering committees, negative results, and scope negotiations.
  • A commercial track record identifying and converting follow-on opportunities within existing accounts.
  • Hands-on experience designing project management systems and automating recurring workflows.
  • Working knowledge of oncology or molecular biology sufficient to lead scientific discussions with teams and partners.
  • Fluency in English.

Responsibilities

  • Act as the primary contact for pharma partners from kick-off through final delivery; map decision-makers, priorities, and expectations for each asset; run steering committees; attend key international conferences a few times per year; and present results alongside scientific teams.
  • Translate signed contracts into executable plans for Wet Lab and Dry Lab teams, with owners, milestones, and deliverables; own timelines, coordinate experimental and computational work, and ensure deliverables pass internal quality control and review before partner delivery.
  • Plan capacity with Wet Lab and Dry Lab leads, arbitrate conflicts among programs, protect committed timelines, and centralize requests to delivery teams from partners and Business Development.
  • Anticipate delivery risks, including results that change the plan, and escalate them to the Scientific Program & Operations Lead with a recommendation; agree and document scope and timeline changes with partners.
  • Scale the project management system in Asana, including program templates, timelines, portfolio and capacity views; automate reporting and follow-up; deploy AI tools where they remove manual work; and document program processes.
  • Identify, qualify, and convert follow-on opportunities within existing partnerships; work with Business Development on scoping, proposals, and pricing; and provide feasibility assessments before commitments are made.
  • Schedule conference and business-development material cycles as part of delivery plans and coordinate partner approvals for communications based on partnered programs.

Desired Qualifications

  • A PhD is a strong plus.
  • Experience in precision oncology or at a pharma-facing contract research organization.
  • Familiarity with patient-derived tumor models, omics, or drug screening.
  • Python scripting or experience deploying automation and artificial intelligence tools.
  • Experience working with statements of work and contracts.
  • Professional French.

About the Company

Orakl Oncology

AI-driven tumor modeling for personalized oncology

Orakl Oncology uses artificial intelligence to analyze experimental and patient data to build tumor models that mirror real drug responses, enabling personalized medicine in oncology. Its AI-powered data analysis identifies cancer biology patterns and translates them into tumor models, which collaborators in the oncology field can use to test and tailor treatments. The product works by integrating diverse data sources and applying AI to simulate how tumors react to different drugs, producing insights and predictive models for decision-making. Compared to competitors, Orakl Oncology focuses on combining AI with both experimental and patient data to create highly representative tumor models and to support B2B partnerships with other oncology companies, not consumer-facing applications. The company aims to help clients develop more effective, personalized cancer therapies by providing data-driven models and analyses that accelerate drug development and precision treatment strategies.

Company size
11-50
Company stage
Series A
Total funding
$49.4M
Headquarters
Paris, France
Founded
2023

Recently Posted Jobs

Explore more opportunities at Orakl Oncology

See more jobs